St. Vincent - Frontier Cancer Center — Billings, Montana

St. Vincent - Frontier Cancer Center is a clinical research site located in Billings, Montana, United States 59102.

Crixeo Health Trust Score: 67/100 (FAIR). This profile has not yet been claimed by the site owner.

St. Vincent - Frontier Cancer Center has participated in 4 clinical trials with 2 currently active.

Therapeutic areas: HER2-positive Breast Cancer, Unresectable or Metastatic Melanoma, Progressive Brain Metastasis.

Sponsors: Seagen, a wholly owned subsidiary of Pfizer, HUYABIO International, LLC., Sumitomo Pharma America, Inc..

Sponsor Feasibility Report

Trust Score: 67/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for St. Vincent - Frontier Cancer Center?

St. Vincent - Frontier Cancer Center has a Crixeo Trust Score of 67/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has St. Vincent - Frontier Cancer Center conducted?

St. Vincent - Frontier Cancer Center has 4 clinical trials on record, with 2 currently active. Their work covers HER2-positive Breast Cancer, Unresectable or Metastatic Melanoma, Progressive Brain Metastasis.

Is St. Vincent - Frontier Cancer Center accredited by Crixeo Health?

St. Vincent - Frontier Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about St. Vincent - Frontier Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.